Tirzepatide, a novel medication, is sparking considerable buzz within the medical community. It functions differently from common diabetes medications, targeting multiple receptors involved in blood regulation and appetite . Initial studies have demonstrated impressive efficacy in lowering blood glucose in individuals with adult-onset diabetes and,